Skip to main content
Caplight Logo









AmarnaBio

AmarnaBio

Private
Chapel Hill, North CarolinaHealthcare & Life Scienceshttps://amarnabio.com/

Last Round

Grant

Mar 13, 2025

Total Funding Raised

$50,000

Company Overview

AmarnaBio is a biotechnology company that uses an AI-driven platform to decode RNA regulatory networks for biomarker and drug target discovery, with a focus on neurological and rare diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Subscription SaaS

AI Layer

Application

Keywords

biomarker discoverytarget discoveryAI drug discoveryRNA analysisbioinformatics platformmulti-omics analysisbiotech AIRNA interactome analysisneurology drug discoveryrare disease drug discoverypatient stratificationnon-coding RNAtarget validationprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AmarnaBio Comparables

Compare AmarnaBio with similar companies based on industry and business-model similarity.

AmarnaBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eclipsebio
86%
Envisagenics
82%
ReviR Therapeutics
82%

AmarnaBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 13, 2025

AmarnaBio Investors

Notable investors and investment history

AmarnaBio investors
InvestorRounds
KickStart Venture ServicesGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 13, 2025

    $50K grant from KickStart Venture Services.

AmarnaBio Filings

Explore SEC and related filing metadata, where available.

AmarnaBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AmarnaBio's valuation, stock price, and market status.

Is AmarnaBio a public or private company?

AmarnaBio is a private company.

What is the current stock price of AmarnaBio?

AmarnaBio is a private company with no public stock price. No recent secondary market data is available.

How much is AmarnaBio worth (valuation)?

Valuation information for AmarnaBio is not publicly available.

Can I buy AmarnaBio stock?

AmarnaBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AmarnaBio's last funding round?

Funding round information for AmarnaBio is not publicly available.

Who are the main investors in AmarnaBio?

Investor information for AmarnaBio is not publicly disclosed.

Will AmarnaBio IPO soon?

No public IPO plans have been announced for AmarnaBio.

How can I track AmarnaBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AmarnaBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChapel Hill, North Carolina
Year FoundedN/A
Last FundingMar 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?